๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of dirlotapide in the dog

โœ Scribed by D. A. MERRITT; M. P. LYNCH; V. L. KING


Book ID
108885199
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
169 KB
Volume
30
Category
Article
ISSN
0140-7783

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


The safety of dirlotapide in dogs
โœ J. A. WREN; V. L. KING; M. J. KRAUTMANN; J. GOSSELLIN; R. L. KERLIN; M. A. HICKM ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB
Pharmacokinetics of reboxetine enantiome
โœ E. Frigerio; A. Benecchi; G. Brianceschi; C. Pellizzoni; I. Poggesi; M. Strolin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive

Pharmacokinetics of 8-methoxypsoralen in
โœ J. G. Monbaliu; F. M. Belpaire; R. A. Braeckman; M. G. Bogaert ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 384 KB ๐Ÿ‘ 1 views

The pharmacokinetics of 8-MOP were studied in six dogs following intravenous administration of 2 mg kg-'. In most animals a bi-exponential decline of the plasma level profile was observed. The calculated pharmacokinetic parameters varied considerably between the different dogs. The mean half-lives o